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Intestinal bile salts (BSs) may be implicated in NEC development. We hypothesized that
fecal BS levels are higher in preterm infants at risk for NEC.
Methods
We compared the composition and concentration of fecal BSs in ten preterm infants who
developed NEC (Bell’s Stage II) with twenty matched control infants without NEC. Conju-
gated and unconjugated fecal BSs were measured after birth (T1) and twice prior to NEC
(T2, T3). Data are presented as medians and interquartile ranges.
Results
GA and BW were similar in all preterms: ~27+4 weeks and ~1010 g. Age of NEC onset was
day 10 (8–24). T1 was collected 2 (1–3) days after birth. T2 and T3 were collected 5 (5–6)
days and 1 (0–2) day before NEC or at corresponding postnatal ages in controls. The com-
position of conjugated BSs did not differ between the two groups. Total unconjugated BSs
were 3-fold higher before NEC compared to controls at corresponding ages (0.41 μmol/g
feces (0.21–0.74) versus 0.14 μmol/g feces (0.06–0.46), p < 0.05).
Conclusion
Fecal BS concentrations are higher in preterm infants who develop NEC compared to
infants without NEC. Further study is needed to determine the predictive value of fecal BSs
in the development of NEC.
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Introduction
It remains unpredictable whether or not a preterm infant will develop NEC, despite well-char-
acterized epidemiological and clinical risk factors such as low gestational age (GA), low birth
weight (LBW), formula feeding, and antibiotic treatment [1]. Early symptoms of NEC are
often non-specific, as are laboratory parameters and radiological examinations. Therefore,
finding parameters that could identify preterm infants at risk of NEC is of great clinical
importance.
It is thought that the accumulation of intestinal bile salts (BSs) is implicated in the develop-
ment of NEC. BSs are the main organic constituents of bile and act as biological detergents
that facilitate intestinal absorption of dietary fats. The so-called primary BSs, i.e. cholate and
chenodeoxycholate, are synthesized from cholesterol in the human liver and are conjugated
with either the amino acid glycine or taurine. The synthesis of BSs already starts in utero, and
BSs can be detected in meconium [2]. Intestinal BS re-uptake occurs mainly in the distal
ileum, i.e. the intestinal segment predominantly affected in NEC. The incidence of NEC is
highest in formula-fed preterm infants. In comparison to term infants it has been shown that
BS levels and BS composition in preterm infants are different and levels of secondary and
more hydrophobic BSs are higher in feces of formula-fed infants than in breast-fed infants
[3,4]. Intraluminal accumulation of hydrophobic BSs can result in intestinal epithelial damage
similar to the histopathological findings in NEC [5]. Previously, biliary hypersecretion of BSs
has been shown to promote NEC development in mice, whereas intraluminal capture of BS in
the intestine by binding agents (e.g. cholestyramine) has been shown to mitigate NEC in a
rodent model [6]. Intestinal damage occurs when high concentrations of intraluminal intesti-
nal BS lead to intracellular intestinal accumulation. The essential role of intestinal BS transport
in the development of NEC has been convincingly demonstrated: NEC is attenuated in mice
deficient in apical sodium-dependent bile salt transporter (ASBT), a protein involved in intes-
tinal BS uptake, and in rats treated with an ASBT inhibitor [6]. In agreement with the postu-
lated role of increased BS uptake in the distal small intestine, ASBT expression (mRNA and
immunohistochemistry) was increased in intestinal samples of preterm infants with NEC in
comparison to ileal samples taken during surgery on preterm infants with other diseases [6].
Furthermore, BSs have been shown to decrease ileal mucin production more profoundly in
immature than in older ileums, and alter the intestinal mucus layer which might compromise
the intestinal barrier function [7].
The foregoing data support the putative role of high intestinal BSs in NEC development.
We hypothesized that high levels of fecal BSs might serve as early parameters to identify infants
with imminent NEC development. Prospectively, we determined fecal BS concentrations and
compositions in preterm infants at risk for NEC. Subsequently, we compared BS parameters of




We obtained written, informed parental consent in all cases. The study was approved by the
ethics review board of University Medical Center Groningen.
Patients
This study was a case-control study and part of a large, prospective observational cohort regis-
tered with the Dutch Trial Registry (trialregister.nl; identifier: NTR4153). The study was
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performed in the NICU of the Beatrix Children’s Hospital of the University Medical Center
Groningen (UMCG) between October 2012 and February 2014. For the purpose of the cohort
study, preterm infants with a GA below 30 weeks, a BW below 1000 grams, or a combination
of a GA below 32 weeks and a BW below 1200 grams were eligible for enrollment within the
first 48 hours after birth. Exclusion criteria consisted of congenital intestinal diseases or
abdominal wall defects. One hundred infants were included in the cohort study. For the pres-
ent study, we selected all infants with NEC (n = 10) and matched two controls from the same
cohort to each infant who developed NEC, using GA and BW, in descending order of impor-
tance, allowing for a maximum deviation of 10%.
Clinical data. We collected all data prospectively. Neonatal data included gender, GA,
BW, twin or singleton, antenatal treatment with steroids, preterm prelabor rupture of mem-
branes>24 hours, Apgar scores at 1, 5, and 10 minutes, antibiotic treatment during first 48
hours after birth, prolonged antibiotic treatment (> 48 hours after birth), hemodynamically
significant patent ductus arteriosus (hsPDA), ibuprofen treatment for hsPDA, time to onset of
enteral feeding and type of enteral feeding. In addition, we recorded the need for mechanical
ventilation, inotropics, fluid resuscitation, and red-blood cell transfusion during the study
period as well as mortality data. Data are in S1 File.
Feeding strategy. Enteral feeding consisted of own mother’s milk, preterm formula, or a
combination if own mother’s milk was not (sufficiently) available in 21 infants. Nine patients
(1 NEC and 8 controls) had been included in the Early Nutrition Study (trialregister.nl; identi-
fier: NTR3225), a RCT comparing effects of pasteurized donor milk or preterm formula during
the first 10 days of life in addition to mother’s own milk in very low birth weight infants
(< 1500 g.) [8]. Enteral feeding was started in all patients according to the local guideline. In
short, preterms with a birth weight < 1250 g. were fed 12 times per 24 hours, and preterm
infants > 1250 g. were fed 8 times daily. Feeding volume was started at 15–20 mL per kg and
was increased daily with the same volume. Breast milk fortifier (Nenatal BMF1, Nutricia, Zoe-
termeer, the Netherlands) was added after the first week when feeding volume was minimally
80 mL/kg/day. Parenteral nutrition was started immediately after birth; amino-acids from the
date of birth and fat emulsions thereafter.
Primary outcome. The primary outcome of this study was a combination of fecal BS con-
centrations and composition in preterm infants who did, or did not, develop NEC. NEC diag-
nosis was defined by the presence of either pneumatosis intestinalis or portal venous gas, or
both according to the modified Bell’s staging criteria (Bell’s Stage II). The diagnosis was
established by the attending radiologist and later confirmed independently by five neonatology
consultants. We defined the time of NEC onset as the first abdominal X-ray after clinical suspi-
cion of the disease. All preterm infants with NEC were treated conservatively with nil per os,
gastric decompression, and broad-spectrum antibiotics until radiographic signs of NEC
resolved and clinical signs stabilized. Surgery was performed when a perforation was suspected
or when the infant deteriorated clinically despite conservative treatment.
Collection of fecal samples
Fecal samples were collected from the diaper in sterile tubes within 48 hours after birth and
subsequently twice weekly on every first and fourth day calculated from birth, until either
NEC Bell’s Stage II occurred, or the infant was transferred to another hospital, or reached
the age of 36 days. If the infant did not produce feces on the predetermined day of feces
sampling, the next feces produced was collected (up op two days after the predetermined sam-
pling day). In controls, selection of feces samples was adjusted according to the closest
Fecal Bile Salts and NEC
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corresponding time point of feces samples from the infants who ultimately developed NEC.
Fecal samples were stored at -80˚C until batch analysis of unconjugated and conjugated BSs.
Fecal bile salt analysis. Fecal BS concentrations were measured in an aliquot of freeze-
dried homogenized feces and determined by capillary gas chromatography (GC) as methyles-
ter-trimethylsilyl derivatives on a Hewlett Packard gas chromatograph (HP 5880 A) as previ-
ously described [9]. GC methodology provides reliable quantitative information on BS species,
irrespective of the conjugation status, as the standard operating procedure includes a deconju-
gation procedure. Unconjugated BS concentrations are expressed in μmol/g dry weight. We
measured the levels of cholate (C), chenodeoxycholate (CDC), deoxycholate (DC), hyocholate
(HC), and hyodeoxycholate (HDC). Total fecal BS levels were calculated as the sum of all mea-
sured individual species. Because more BS species exist, the absolute level of total BSs should
be read as total measured BSs. The lower limit of detection of unconjugated BSs varies between
0.3 and 0.5 nmol dry weight feces, but is slightly dependent on the BS species (C: 0.4 nmol,
CDC: 0.4 nmol, DC: 0.3 nmol, HC: 0.4 nmol, HDC: 0.5 nmol). Fecal conjugated BS composi-
tion was measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). This
system consists of a Shimadzu liquid chromatography system (Shimadzu, Kyoto, Japan) cou-
pled to a Sciex API-3200 triple quadrupole mass spectrometer with an electrospray ionization
(ESI) source (Sciex, Framingham, Massachusetts, USA). In short, about 50 mg of freeze-dried
homogenized feces was weighed exactly and extracted with 2 mL of alkaline methanol for two
hours at 80˚C. After cooling down to room temperature, 8 mL of demineralized water was
added and the tubes were vortexed. After adding 250 μL internal standard solution to 1 mL of
sample solution, the samples were prepared for analysis using solid phase extraction (SPE).
After SPE, the samples were dried using N2 at 40˚C, and the samples were redissolved in
500 μL 50% methanol. Finally, the samples were filtered with 0.2 μm spin filters. Ten μL of
sample was injected into the LC-MS/MS system. The BS species we evaluated were glycocho-
late (GC), taurocholate (TC), glycochenodeoxycholate (GCDC), and taurochenodeoxycholate
(TCDC). Data are in S2 File and in S3 File. In theory, the LC-MS/MS method may be used to
detect both the conjugated and unconjugated BA. However, we identified two important limi-
tations for BS measurements in feces by LC-MS/MS: i) In feces there were abundant interfer-
ing compounds in the chromatograms. This feature made it hard, and for some BS even
impossible to reliably obtain quantitative information of BS concentrations. We only could
determine concentrations of a specific BS when its peak in the chromatogram and the corre-
sponding internal-standard were sufficiently separated and not disturbed by apparently inter-
fering compounds. ii) The linear range in which BSs can be accurately detected was much
smaller with the LC-MS/MS methodology compared to the GC methodology. For the LC-MS/
MS method samples had to be diluted extensively, which may have reduced levels of some of
the BSs even below the detection limit.
Statistical analysis
All data of fecal BSs are presented as medians and interquartile ranges (IQR) unless specified
otherwise. Either odds ratios (and 95% confidence intervals (CIs)) or the Mann-Whitney test
was used to analyze differences in clinical characteristics, as appropriate. The Median Test
(one-tailed) was used to compare levels of fecal unconjugated BS concentrations and of per-
centages of conjugated BS profiles between the two groups at the three different points in time
(independent variables). The Wilcoxon signed Rank Test (two-tailed) was used to compare
median levels of fecal BS concentrations within subgroups (dependent variables). Cut-off val-
ues for NEC prediction were investigated with receiver operating characteristics (ROC) analy-
ses. The level of significance for statistical analyses was set at p< 0.05. All analyses were
Fecal Bile Salts and NEC
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performed using SPSS 22.0 software for Windows (IBM SPSS Statistics 22, IBM Corporation,
Armonk, New York, USA).
Results
Patient characteristics
Ten preterm infants developed NEC during the study period at a median age of 10 (4–30) days
after birth. Bell’s Stage II occurred in two infants and Bell’s Stage III in eight. Seven infants
underwent surgery. In one infant surgery was indicated but not performed due to the infant’s
poor clinical condition. Three out of the ten infants who developed NEC died as a conse-
quence of the disease. Table 1 shows that demographic and clinical characteristics were not sig-
nificantly different between the infants who did, or those who did not, develop NEC.
Feces sampling
A total of 76 fecal BS samples were available for analysis of preterm infants: 25 samples of
infants who ultimately developed NEC and 51 samples of control infants. Unconjugated BSs
could be measured in 59 samples (24 NEC and 35 controls), and conjugated BSs could be mea-
sured in 69 samples (22 NEC and 47 controls). In all infants, the first feces sample (T1) was
Table 1. Patient characteristics.
NEC (n = 10) No NEC (n = 20) OR (95%-CI)
GA, weeks 27.5 (24.6–29.4) 27.6 (25.3–29.9)
BW, grams 1010 (775–1630) 1013 (615–1735)
Male: Female 5:5 11:9
Apgar score 10’ 8 (4–10) 8 (7–10)
Postnatal age NEC (days) 9.5 (4–30) NA
DCDA gemelli (%) 30 30 1 (0.19–5.24)
Antenatal steroids (%) 90 90 1 (0.08–12.56)
PPROM (%) 70 35 4.3 (0.85–22.23)
Mechanical ventilation (%) 70 55 1.9 (0.38–9.59)
hsPDA—NSAID (%) 40 35 1.24 (0.26–5.91)
Enteral feeding < 24 hrs (%) 100 100
Type of feeding
MM 2 4 1 (0.15–6.67)
MM+DM 0 2 0 (0-1)
MM+PF 5 13 0.54 (0.11–2.51)
PF 3 1 8.14 (0.72–91.89)
Antibiotics first 48 hrs (%) 90 85 1.59 (0.14–17.56)
LOS (%) 70 35 4.3 (0.84–22.23)
Saline infusion (%) 60 45 1.83 (0.39–8.57)
Inotropes (%) 40 10 6 (0.87–41.4)
RBC transfusion (%) 80 65 2.15 (0.36–13.05)
Mortality (%) 30 10 3.86 (0.53–28.24)
Postnatal day of death 27 (6–33) 8.5 (6–11)
Data are expressed as median (range) or as numbers unless specified otherwise. DCDA, dichorionic
diamniotic; PPROM, preterm prelabour ruptures of membranes > 24 h.; hsPDA, hemodynamically
significant patent ductus arteriosus; NSAID, nonsteroidal anti-inflammatory drug; MM, mother’s milk; PF,
preterm formula, DM, donor milk; LOS, late onset sepsis; RBC, red blood cell; N.A., not applicable.
doi:10.1371/journal.pone.0168633.t001
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collected at a median of 2 days after birth (IQR 1–3). In all infants, the two consecutive samples
taken immediately prior to the diagnosis of NEC, T2 and T3, were collected at a median of 5
days (IQR: 5–6) and 1 day (IQR: 0–2) before onset of NEC, respectively. In NEC infants, the
last feces sample was collected at a median (IQR) of 1.5 (0–3) day before NEC occurred. In
controls, median (IQR) day of life (DOL) at T2 was 5 (4–21.5) days, compared to 7.5 (4–20) in
the NEC infants (NS). Median (IQR) DOL at T3 was 11.5 (8–24) in controls and 12 (8–12) in
NEC infants (NS).
Total fecal bile salts
Total unconjugated bile salts. Total BS concentrations were not significantly different in
the first feces samples after birth (T1) between the NEC group and the controls (Fig 1). At T2,
Fig 1. Box plot of total BS concentrations. The median is marked by the horizontal line in the central box. The boxes are limited by the
25th and 75th percentiles. The whiskers (┴) represent the lowest and highest total BS within 1.5 interquartile distance below or above the
box. Outliers () represent BS concentrations between 1.5 and 3 interquartile distances below or above the box. Extremes (▲) represent
BS concentrations more than 3 interquartile distances above the box. Feces was collected at three different points in time; within three
days after birth (T1), five to six days prior to NEC (T2), zero to two days prior to NEC (T3). Total BS concentration: sum of all individual BS
concentrations, irrespective of the conjugation status, detected with gas chromatography and expressed in μmol/g dry weight feces.*:
p < 0.05, **: p < 0.1 (T3: p = 0.07).
doi:10.1371/journal.pone.0168633.g001
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which corresponded to five days prior to NEC, total unconjugated BSs were four times higher
in the NEC group than in the controls (0.65 μmol/g feces (0.49–0.97) versus 0.16 μmol/g feces
(0.48–0.99), p = 0.02). In the feces samples at T3, one day prior to NEC, total unconjugated
BSs were two-and-a half times higher in the NEC group than in the controls (0.29 μmol/g feces
(0.19–0.46) versus (0.13 μmol/g feces (0.05–0.37), p = 0.07). When the fecal samples of T2 and
T3 were analyzed together, we found that total unconjugated BSs were significantly increased
in infants developing NEC (median 0.41 μmol/g feces (0.21–0.74) versus 0.14 μmol/g feces
(0.06–0.46), p = 0.03).
We observed no statistically significant decrease in total fecal unconjugated BSs between
any of the time points in the infants developing NEC. The decrease in total BSs was statistically
significant in the controls between T1 (0.86 μmol/g feces (0.55–1.41) and T2 (0.16 μmol/g
feces (0.05–0.99), p = 0.01, Fig 1), and also between T1 and T3 (-85%, p< 0.05).
Unconjugated bile salt species. Of unconjugated BSs, chenodeoxycholate (CDC) was the
only unconjugated BS species that showed a trend toward significance between the NEC group
and the controls. Unconjugated CDC concentrations were higher in the infants developing
NEC in the week prior to NEC (0.18 μmol/g feces (0.13–0.43) versus 0.08 μmol/g feces (0.03–
0.28), p = 0.06). Fig 2 shows the specific BS as a percentage of the total measured BS concentra-
tion at three different time points before NEC occurred or in a matched control sample. The
primary BSs cholate (C) and chenodeoxycholate (CDC) were abundant at all time points in
preterm infants who developed NEC and also in matched control infants. HC and/or HDC,
that are rare in humans, were present in 7 of 24 (29%) samples of NEC patients and in 9 of 35
(26%) samples of controls (NS). In the last feces sample before NEC occurred, HC was present
in 3 of 8 samples in NEC infants, and in 1 of 10 control samples (NS).
NEC prediction with receiver operating characteristic data. The ROC curve of total BSs
at T2 and T3 illustrated that total unconjugated BS> 0.13 μmol/g feces tended to predict NEC
with 93% sensitivity and 47% specificity (area under curve (AUC) 0.74. 95% CI 0.57–0.91;
p = 0.02, Fig 3).
Fecal conjugated bile salts. Fig 4 shows the composition of conjugated BSs in both the
NEC group and the controls. We found no statistically significant differences in fecal conju-
gated BS composition at the three sampling points between preterm infants who developed
NEC and controls.
Discussion
Our aim was to determine whether fecal BS analysis could, potentially, provide an early marker
for the development of NEC in preterm infants. We demonstrated a significantly higher level
of total fecal BSs in the week before NEC started to develop compared to corresponding sam-
ples in GA and BW matched controls. Yet, the differences in the composition of conjugated
fecal BSs at any of the three time points were not statistically significant between the NEC
group and the controls. The difference in fecal BS could also not be attributed to major differ-
ences in specific, individual unconjugated BS. Apparently, the decrease was quantitative more
that qualitative, and the variation in individual BS concentrations precluded statistical signifi-
cance. Taking into consideration the sensitivity and specificity of fecal BSs for the development
of NEC, it seems impossible at this stage to predict the onset of NEC using fecal BS analysis in
preterm infants.
Our results are in accordance with previous analyses of total BS concentrations in neonates,
i.e. with respect to the highest levels for total BSs in meconium [10]. In our study, apart from
unconjugated BSs, we also detected conjugated BS species in the first available fecal samples,
i.e. within the first three days after birth. In analogy to previous data, including biliary and
Fecal Bile Salts and NEC
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duodenal BSs in preterm and term infants, taurine-conjugated BSs predominated [11,12]. BS
conjugation increases hydrophilicity, which promotes aqueous solubility at intestinal pH, and
if intravascular, it facilitates renal excretion, thus minimizing the membrane damaging proper-
ties of the more hydrophobic unconjugated bile salts [13]. In the intestines, particularly in the
colon, conjugated cholate and chenodeoxycholate may undergo deconjugation, and can be
substrates for dehydroxylation by bacterial flora, resulting in deoxycholate and lithocholate,
which are more toxic. Animal data, and preliminary human data as well, have implicated intes-
tinal BSs in the development of NEC [5]. Bile salt levels in intestinal tissue are increased in
rodents with experimentally induced NEC and reduction of intestinal BS reabsorption by
enteral administration of cholestyramine decreases both its rate and severity [5]. Moreover,
rate as well as severity of experimental NEC were reduced in apical sodium-dependent bile
acid transporter (ASBT) knockout mice, and also in rats in which ASBT was pharmacologi-
cally inhibited [6]. Finally, more severe NEC was demonstrated in genetically manipulated
mice which hypersecrete biliary BSs, resulting in increased concentrations of intestinal BSs. In
Fig 2. Percentage of specific bile salts (BSs) at three time points. Specific BSs were measured at three different time points before
NEC occurred or in a matched control sample with GC methodology as explained in the Methods section. Specific BS (hyocholate (HC),
hyodeoxycholate (HDC), chenodeoxycholate (CDC), Cholate (C), and deoxycholate (DC)) are given as percentage of the total measured
BSs.
doi:10.1371/journal.pone.0168633.g002
Fecal Bile Salts and NEC
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accordance, increased mRNA levels of ASBT in ileal tissue of preterm infants with NEC is sug-
gestive of increased BS uptake into enterocytes [6]. In our study, total unconjugated BSs in
feces decreased at a slower rate before NEC development in comparison to controls. Similar to
our data of higher total BSs levels in feces of preterm infants prior to NEC, intestinal luminal
BSs levels in rodents subjected to experimental NEC were higher than in control animals [14].
To some extent, our findings are also in agreement with preliminary data on serial total fecal
BS excretion in two preterm neonates with comparable GA and BW, i.e. 29 weeks and 1050
grams, who developed NEC (personal communication with professor M.D. Halpern, Univer-
sity of Arizona). Increases of total fecal BSs and higher coefficients of variation were demon-
strated in these preterm infants. On the basis of previous animal and human data, higher fecal
BS concentrations could be anticipated upon after birth in preterm infants with imminent
NEC. It is tempting to speculate that this transient failure to decrease BSs coincides with
increased levels of intraenterocytic BSs of the preterm intestine. A prerequisite would be suffi-
cient activity or even upregulation of ASBT in the immature intestine, in which the negative
feedback of intestinal BSs on ASBT, and on intestinal BS uptake, is abnormal or does not yet
occur. Whether intestinal microbiota affect the expression of ASBT in preterm infants, as was
previously reported in mice, is unknown [15].
Fig 3. Receiver operating characteristic (ROC) curve of total fecal BS concentrations in the week prior
to NEC onset.
doi:10.1371/journal.pone.0168633.g003
Fecal Bile Salts and NEC
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We acknowledge several limitations to our study and results. Obviously, due to its size, our
sample lacked the power to discriminate between a normal and a slow albeit “NEC-predispos-
ing” decay pattern of fecal BSs. A substantial larger sample size (i.e., of at least 50 NEC infants)
would be required for sufficient power. Secondly, measurement of fecal BSs on one particular
day does not allow one to predict whether and if so when NEC will occur: serial measurements
from birth until NEC onset should be obtained to assess the decay of fecal BSs. Thirdly, higher
levels of fecal BSs, or a slower decrease in fecal BSs, may help to identify preterm infants with
an increased risk of developing NEC, but it remains unknown how we can reduce the risk of
NEC in these particular infants. Finally, no data on the fecal microbiome, that would affect bile
salt composition, were provided.
The applied GC methodology allows for reliable and fast quantification of many BSs in a
way that may more or less be routinely incorporated in clinical care for preterm infants. Yet,
we could not detect either conjugated or unconjugated BS in some feces samples. Upon its
consistency upon reanalysis, it is tempting to speculate that—apart from any methodological
issues—variations in the developing microbiome of the immature intestine in preterm infants
is responsible for these variations. We did not choose any (un)conjugated at forehand. Rather,
these particular BS species appeared to be present upon analysis by our methodology. Interest-
ingly, HC and HDC are usually not detected in appreciable amounts in (adult) humans. The
presence of these BS species in some of the samples is not clarified. The observation that they
are found both in NEC and in non-NEC feces pleads against an important pathophysiological
role in the development of NEC.
Despite predictive clinical risk factors NEC remains a multifactorial disease with rapid
unpredictable onset of intestinal damage for which powerful predictive biochemical markers
Fig 4. Composition of fecal conjugated bile salts. Feces were collected at three different points in time:
within three days after birth (T1), four to six days prior to NEC (T2), zero to two days prior to NEC (T3). Fecal
conjugated bile salt species were measured with LC-MS/MS as described in the Methods section.
doi:10.1371/journal.pone.0168633.g004
Fecal Bile Salts and NEC
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are urgently needed, but these are, as yet, unavailable [16,17]. The slower decay of fecal BSs
provides support for altered BS metabolism in the development of NEC in humans. Further
study, with serial measurements of fecal BSs in a large number of high-risk infants, is needed
to firmly establish the role of fecal BSs in the prediction of NEC in preterm infants.
Conclusion
In preterm infants who develop NEC, the levels of fecal BSs are higher in the week preceding
NEC than in controls. Serial measurement of fecal BSs may help to identify preterm infants
who are vulnerable to developing NEC.
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